Ken Inoki

30.3k citations
99 papers · 23.1k · 11 hit papers · h-index 57

Impact in

Papers in

    • PI3K/AKT/mTOR signaling in cancer 46
    • Metabolism, Diabetes, and Cancer 8
    • TGF-β signaling in diseases 3
    • Chronic Kidney Disease and Diabetes 9
    • Renal Diseases and Glomerulopathies 9

Ken Inoki

96 papers receiving 22.7k citations

Ken Inoki's Hit Papers

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1 2021 · 2.1k citations
2.1k0+8+16Years since publication1k2k3k

Peers

Ken Inoki
Comparison fields: 5 of 154
  • Aging 506
  • Epidemiology 5.6k
  • Nephrology 1.6k
  • Molecular Biology 9.4k
  • Cell Biology 1.3k
Replace Mondira Kundu with:
Mondira Kundu United States
Hiromi Sesaki United States
Mary E. Choi United States
Jan B. Parys Belgium
Do‐Hyung Kim United States
Guillermo Mariño France
Masashi Narita United Kingdom
Jorge Moscat United States
Jeffrey M. Robbins United States
Viktor I. Korolchuk United Kingdom
Ken Inoki relative to Mondira Kundu United States Mondira Kundu's profile →
Citations per field
00.5×2×3×4×4.7×
Mondira Kundu · 1×
Citations per year

Countries citing papers authored by Ken Inoki

Since Specialization
Citations

This map shows the geographic impact of Ken Inoki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Inoki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Inoki more than expected).

Fields of papers citing papers by Ken Inoki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Inoki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Inoki. The network helps show where Ken Inoki may publish in the future.

Co-authors

The 25 scholars most cited alongside Ken Inoki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ken Inoki Line = papers co-authored together Ken Inoki links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 99 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Guidelines for the use and interpretation of assays for monitoring autophagy
Hit paper breakdown →
20123543
2
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Hit paper breakdown →
20033303
3
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Hit paper breakdown →
20022569
4
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1
Hit paper breakdown →
20212067
5
TSC2 Integrates Wnt and Energy Signals via a Coordinated Phosphorylation by AMPK and GSK3 to Regulate Cell Growth
Hit paper breakdown →
20061154
6
Dysregulation of the TSC-mTOR pathway in human disease
Hit paper breakdown →
2004840
7
AMPK and mTOR in Cellular Energy Homeostasis and Drug Targets
Hit paper breakdown →
2011682
8
ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS
Hit paper breakdown →
2010636
9 2008516
10
Spatial Coupling of mTOR and Autophagy Augments Secretory Phenotypes
Hit paper breakdown →
2011494
11
Role of mTOR in podocyte function and diabetic nephropathy in humans and mice
Hit paper breakdown →
2011484
12
mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice
Hit paper breakdown →
2011479
13 2005280
14 2012231
15 2004207
16 2005207
17 2008207
18 2013195
19 2006190
20 2019190

About Ken Inoki

Ken Inoki is a scholar working on Molecular Biology, Nephrology, Epidemiology, Physiology and Cell Biology, having authored 99 papers that have together received 23.1k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (46 papers), Autophagy in Disease and Therapy (14 papers), Chronic Kidney Disease and Diabetes (9 papers), Renal Diseases and Glomerulopathies (9 papers), Tuberous Sclerosis Complex Research (8 papers), Metabolism, Diabetes, and Cancer (8 papers), TGF-β signaling in diseases (3 papers) and Cellular transport and secretion (3 papers). The work is most often cited by research in Aging (506 citations), Epidemiology (5.6k citations), Nephrology (1.6k citations), Molecular Biology (9.4k citations) and Cell Biology (1.3k citations). Ken Inoki has collaborated with scholars based in United States, Japan and Singapore. Frequent co-authors include Kun‐Liang Guan, Tianqing Zhu, Yong Li, Tianquan Zhu, Michael Nino Corradetti, Joungmok Kim, Tsuneo Ikenoue, Qian Yang, Hongjiao Ouyang and Sei Yoshida. Their work appears in journals such as Journal of Biological Chemistry, Proceedings of the National Academy of Sciences, Journal of the American Society of Nephrology, Journal of Clinical Investigation and Kidney International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact